TMCnet News
BeiGene to Present at the Guggenheim Healthcare Talks Idea Forum - Oncology DayCAMBRIDGE, Mass., and BEIJING, China, Feb. 07, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced that the company will present at the Guggenheim Healthcare Talks Idea Forum – Oncology Day in New York, NY. The presentation is scheduled for 2:30 p.m. EST on Thursday, February 14, 2019. A live webcast can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com/. An archived replay will be available for 90 days following the event. About BeiGene Investor Contact Media Contact ________________________________ i ABRAXANE®, REVLIMID®, and VIDAZA® are registered trademarks of Celgene Corporation. |